These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 19524507)

  • 1. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.
    Valastyan S; Reinhardt F; Benaich N; Calogrias D; Szász AM; Wang ZC; Brock JE; Richardson AL; Weinberg RA
    Cell; 2009 Jun; 137(6):1032-46. PubMed ID: 19524507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis.
    Valastyan S; Chang A; Benaich N; Reinhardt F; Weinberg RA
    Cancer Res; 2010 Jun; 70(12):5147-54. PubMed ID: 20530680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro.
    Lv XB; Jiao Y; Qing Y; Hu H; Cui X; Lin T; Song E; Yu F
    Chin J Cancer; 2011 Dec; 30(12):821-30. PubMed ID: 22085528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.
    Lei R; Tang J; Zhuang X; Deng R; Li G; Yu J; Liang Y; Xiao J; Wang HY; Yang Q; Hu G
    Oncogene; 2014 Mar; 33(10):1287-96. PubMed ID: 23474751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant suppression of three target genes can explain the impact of a microRNA on metastasis.
    Valastyan S; Benaich N; Chang A; Reinhardt F; Weinberg RA
    Genes Dev; 2009 Nov; 23(22):2592-7. PubMed ID: 19875476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of miR-31 function in already-established metastases elicits metastatic regression.
    Valastyan S; Chang A; Benaich N; Reinhardt F; Weinberg RA
    Genes Dev; 2011 Mar; 25(6):646-59. PubMed ID: 21406558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-30 Family Members Inhibit Breast Cancer Invasion, Osteomimicry, and Bone Destruction by Directly Targeting Multiple Bone Metastasis-Associated Genes.
    Croset M; Pantano F; Kan CWS; Bonnelye E; Descotes F; Alix-Panabières C; Lecellier CH; Bachelier R; Allioli N; Hong SS; Bartkowiak K; Pantel K; Clézardin P
    Cancer Res; 2018 Sep; 78(18):5259-5273. PubMed ID: 30042152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
    Ma L; Teruya-Feldstein J; Weinberg RA
    Nature; 2007 Oct; 449(7163):682-8. PubMed ID: 17898713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.
    Liu Q; Wang W; Yang X; Zhao D; Li F; Wang H
    Oncol Rep; 2016 Jul; 36(1):189-96. PubMed ID: 27175941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11.
    Cai WL; Huang WD; Li B; Chen TR; Li ZX; Zhao CL; Li HY; Wu YM; Yan WJ; Xiao JR
    Mol Cancer; 2018 Jan; 17(1):9. PubMed ID: 29343249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer.
    Yu SJ; Hu JY; Kuang XY; Luo JM; Hou YF; Di GH; Wu J; Shen ZZ; Song HY; Shao ZM
    Clin Cancer Res; 2013 Mar; 19(6):1389-99. PubMed ID: 23340296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
    Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
    Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous human microRNAs that suppress breast cancer metastasis.
    Tavazoie SF; Alarcón C; Oskarsson T; Padua D; Wang Q; Bos PD; Gerald WL; Massagué J
    Nature; 2008 Jan; 451(7175):147-52. PubMed ID: 18185580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Ge F; Wang C; Wang W; Liu W; Wu B
    Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
    Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
    Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.
    Ma F; Zhang J; Zhong L; Wang L; Liu Y; Wang Y; Peng L; Guo B
    Gene; 2014 Feb; 535(2):191-7. PubMed ID: 24315818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1.
    Yang S; Li Y; Gao J; Zhang T; Li S; Luo A; Chen H; Ding F; Wang X; Liu Z
    Oncogene; 2013 Sep; 32(36):4294-303. PubMed ID: 23001043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
    Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y
    Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.